GZMK and COVID-19: Similar to GZMA, PRF1, GZMK and GZMB in T cells, significant increases in CASP3 were also present in COVID-19 patients with encephalopathy, and the highest expression of this gene was observed in acute necrotizing encephalopathy patients (Fig. 4e).